TickerFactsScreenerDevelopers

REGENERON PHARMACEUTICALS, INC. (REGN) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2007: $459.35M2008: $421.51M2009: $396.76M2010: $527.82M2011: $485.73M2012: $1.26B2013: $1.96B2014: $2.55B2015: $3.65B2016: $4.45B2017: $6.14B2018: $8.76B2019: $11.09B2020: $11.03B2021: $18.77B2022: $22.66B2023: $25.97B2024: $29.35B2025: $31.26B$31.26B
2007Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$31.26B+6.5%
2024$29.35B+13.0%
2023$25.97B+14.6%
2022$22.66B+20.8%
2021$18.77B+70.2%
2020$11.03B-0.6%
2019$11.09B+26.6%
2018$8.76B+42.5%
2017$6.14B+38.1%
2016$4.45B+21.7%
2015$3.65B+43.3%
2014$2.55B+29.8%
2013$1.96B+56.3%
2012$1.26B+158.7%
2011$485.73M-8.0%
2010$527.82M+33.0%
2009$396.76M-5.9%
2008$421.51M-8.2%
2007$459.35M—